Clarified Precision Medicine
Linda Greub, CFA, MBA, serves as a Board Member at Clarified Precision Medicine and holds the position of Managing Partner at Avestria Ventures. As a Member of the Board of Directors for Mae, Linda also provides insights as a Board Observer for both Raydiant Oximetry, Inc. and AmplifiDx. With a strong background in finance and business administration, Linda Greub brings valuable expertise to their various leadership roles.
This person is not in the org chart
This person is not in any teams
Clarified Precision Medicine
Clarified Precision Medicine is the first scalable molecular tumor board with a combination of AI-based platform plus medical group, offering expert clinical somatic and pharmacogenomics consultations through its ClarifiedSelect™ and OncoGuardian™ solutions. Clarified accelerates the delivery of guidelines-based genomic insights to patients and providers by bringing together nationally recognized experts in medical oncology, oncology pharmacy, data integration, and molecular pathology who have over 100 years of collective experience in the application of precision oncology. For more information, visit: www.clarifiedprecisionmedicine.com